Atiratecan,867063-97-6

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Atiratecan

CAS No. : 867063-97-6

MCE 国际站：Atiratecan

产品活性：Atiratecan (TP300) 是喜树碱类似物 CH0793076 (HY-107096) 的前体。Atiratecan 不抑制乙酰胆碱酯酶 (AChE) 活性。Atiratecan 在小鼠异种移植模型中显示出对乳腺癌抗性蛋白 (BCRP) 阳性和阴性异种移植物的抗肿瘤活性。

研究领域：Cell Cycle/DNA Damage

作用靶点：Topoisomerase

In Vitro: Atiratecan (TP300) is stable in an acidic solution but is rapidly converted to CH0793076 under physiological pH conditions such as in sera.
Atiratecan has antiproliferative activity against camptothecin-resistant cell lines. Atiratecan has IC₅₀s of 9.4 nM and 1.1 nM for A2780 and A2780/SN75 cells, respectively.

In Vivo: Atiratecan (TP300; 47 mg/kg; IV; once per week for 3 weeks) shows more than 50% of tumor growth inhibition in all nine models, regardless of the expression of BCRP.
Atiratecan (24 mg/kg; IV; once per week for 6 weeks) in combination with capecitabine results in synergistic eVects in the HCT116 human colon cancer and NCI-N87 human gastric cancer xenograft models and an additive eVect in the WiDr human colon cancer xenograft model which is BCRP-positive and CPT-11-insensitive.
The eVective dose range of Atiratecan is between 0.30 and 47 mg/kg (MTD/ED₅₀=157). The toxic dose is 63 mg/kg for Atiratecan.

相关产品：Doxorubicin hydrochloride  |  Etoposide  |  Exatecan mesylate  |  SN-38  |  Irinotecan  |  Camptothecin  |  Topotecan hydrochloride  |  Daunorubicin hydrochloride  |  Mitoxantrone  |  Berberine chloride  |  Epirubicin hydrochloride  |  Ciprofloxacin  |  Levofloxacin  |  Betulinic acid  |  EIDD-1931  |  Suramin sodium salt  |  Idarubicin hydrochloride  |  Gepotidacin  |  β-Lapachone  |  Aldoxorubicin  |  Pirarubicin  |  Teniposide

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds